232 related articles for article (PubMed ID: 38530197)
21. Multifaceted roles of RNA editing enzyme ADAR1 in innate immunity.
Jarmoskaite I; Li JB
RNA; 2024 Apr; 30(5):500-511. PubMed ID: 38531645
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the double-stranded RNA response through ADAR1 licenses metaplastic reprogramming in gastric epithelium.
Sáenz JB; Vargas N; Cho CJ; Mills JC
JCI Insight; 2022 Feb; 7(3):. PubMed ID: 35132959
[TBL] [Abstract][Full Text] [Related]
23. ADAR1, inosine and the immune sensing system: distinguishing self from non-self.
Liddicoat BJ; Chalk AM; Walkley CR
Wiley Interdiscip Rev RNA; 2016; 7(2):157-72. PubMed ID: 26692549
[TBL] [Abstract][Full Text] [Related]
24. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
Pfaller CK; George CX; Samuel CE
Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
[TBL] [Abstract][Full Text] [Related]
25. The p150 Isoform of ADAR1 Blocks Sustained RLR signaling and Apoptosis during Influenza Virus Infection.
Vogel OA; Han J; Liang CY; Manicassamy S; Perez JT; Manicassamy B
PLoS Pathog; 2020 Sep; 16(9):e1008842. PubMed ID: 32898178
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin-dependent Turnover of Adenosine Deaminase Acting on RNA 1 (ADAR1) Is Required for Efficient Antiviral Activity of Type I Interferon.
Li L; Qian G; Zuo Y; Yuan Y; Cheng Q; Guo T; Liu J; Liu C; Zhang L; Zheng H
J Biol Chem; 2016 Nov; 291(48):24974-24985. PubMed ID: 27729454
[TBL] [Abstract][Full Text] [Related]
27. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
[TBL] [Abstract][Full Text] [Related]
28. ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation.
Hu SB; Heraud-Farlow J; Sun T; Liang Z; Goradia A; Taylor S; Walkley CR; Li JB
Mol Cell; 2023 Nov; 83(21):3869-3884.e7. PubMed ID: 37797622
[TBL] [Abstract][Full Text] [Related]
29. To "Z" or not to "Z": Z-RNA, self-recognition, and the MDA5 helicase.
Herbert A
PLoS Genet; 2021 May; 17(5):e1009513. PubMed ID: 33983939
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response.
Pfaller CK; Li Z; George CX; Samuel CE
Curr Opin Immunol; 2011 Oct; 23(5):573-82. PubMed ID: 21924887
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.
Kung CP; Cottrell KA; Ryu S; Bramel ER; Kladney RD; Bao EA; Freeman EC; Sabloak T; Maggi L; Weber JD
Oncogene; 2021 Jan; 40(1):189-202. PubMed ID: 33110236
[TBL] [Abstract][Full Text] [Related]
32. Stress granule formation induced by measles virus is protein kinase PKR dependent and impaired by RNA adenosine deaminase ADAR1.
Okonski KM; Samuel CE
J Virol; 2013 Jan; 87(2):756-66. PubMed ID: 23115276
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency.
Mehdipour P; Marhon SA; Ettayebi I; Chakravarthy A; Hosseini A; Wang Y; de Castro FA; Loo Yau H; Ishak C; Abelson S; O'Brien CA; De Carvalho DD
Nature; 2020 Dec; 588(7836):169-173. PubMed ID: 33087935
[TBL] [Abstract][Full Text] [Related]
34. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
[TBL] [Abstract][Full Text] [Related]
35. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
Nakahama T; Kawahara Y
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
[TBL] [Abstract][Full Text] [Related]
36. RNA editing and immune control: from mechanism to therapy.
Hu SB; Li JB
Curr Opin Genet Dev; 2024 Jun; 86():102195. PubMed ID: 38643591
[TBL] [Abstract][Full Text] [Related]
37. Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response.
Choi H; Kwon J; Cho MS; Sun Y; Zheng X; Wang J; Bouker KB; Casey JL; Atkins MB; Toretsky J; Han C
Cancer Res; 2021 Jul; 81(13):3607-3620. PubMed ID: 33941613
[TBL] [Abstract][Full Text] [Related]
38. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR.
Toth AM; Li Z; Cattaneo R; Samuel CE
J Biol Chem; 2009 Oct; 284(43):29350-6. PubMed ID: 19710021
[TBL] [Abstract][Full Text] [Related]
39. Chimeric double-stranded RNA-specific adenosine deaminase ADAR1 proteins reveal functional selectivity of double-stranded RNA-binding domains from ADAR1 and protein kinase PKR.
Liu Y; Lei M; Samuel CE
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12541-6. PubMed ID: 11070079
[TBL] [Abstract][Full Text] [Related]
40. Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection.
Nie Y; Hammond GL; Yang JH
J Virol; 2007 Jan; 81(2):917-23. PubMed ID: 17079286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
